Serum CEA, an oncofetal glycoprotein that is normally expressed by mucosal cells and often overexpressed various malignancies, can sometimes be helpful in monitoring for colon cancer recurrence or progression. This evidence concerns the gene CEACAM5 and malignant colon neoplasm.